124 related articles for article (PubMed ID: 37673783)
1. Insulin-like Factor 3, Basal and Human Chorionic Gonadotropin-Stimulated Testosterone as Biomarkers to Predict the Effect of Testosterone Replacement in Testicular Cancer Survivors With Mild Leydig Cell Insufficiency.
Medici C; Jørgensen N; Juul A; Albrethsen J; Kreiberg M; Lauritsen J; Wagner T; Rosenvilde J; Daugaard G; Bandak M
Clin Genitourin Cancer; 2024 Feb; 22(1):e106-e112.e4. PubMed ID: 37673783
[TBL] [Abstract][Full Text] [Related]
2. A randomized double-blind single center study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention).
Kreiberg M; Jørgensen N; Juul A; Lauritsen J; Oturai P; Helge JW; Christensen JF; Aksglaede L; Schauer T; Wagner T; Rosenvilde J; Grunwald E; Dehlendorff C; Daugaard G; Bandak M
Clin Genitourin Cancer; 2022 Oct; 20(5):404-414. PubMed ID: 35701334
[TBL] [Abstract][Full Text] [Related]
3. Effect of Testosterone Replacement Therapy on Quality of Life and Sexual Function in Testicular Cancer Survivors With Mild Leydig Cell Insufficiency: Results From a Randomized Double-blind Trial.
Højer EG; Kreiberg M; Dehlendorff C; Jørgensen N; Juul A; Lauritsen J; Wagner T; Rosenvilde J; Daugaard G; Bandak M
Clin Genitourin Cancer; 2022 Aug; 20(4):334-343. PubMed ID: 35514022
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like factor 3, luteinizing hormone and testosterone in testicular cancer patients: effects of β-hCG and cancer treatment.
Steggink LC; van Beek AP; Boer H; Meijer C; Lubberts S; Oosting SF; de Jong IJ; van Ginkel RJ; Lefrandt JD; Gietema JA; Nuver J
Andrology; 2019 Jul; 7(4):441-448. PubMed ID: 30609309
[TBL] [Abstract][Full Text] [Related]
5. A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention).
Bandak M; Jørgensen N; Juul A; Lauritsen J; Kreiberg M; Oturai PS; Helge JW; Daugaard G
BMC Cancer; 2017 Jul; 17(1):461. PubMed ID: 28673265
[TBL] [Abstract][Full Text] [Related]
6. Effect of 12-months testosterone replacement therapy on bone mineral density and markers of bone turnover in testicular cancer survivors - results from a randomized double-blind trial.
Jørgensen PL; Kreiberg M; Jørgensen N; Juul A; Oturai PS; Dehlendorff C; Lauritsen J; Wagner T; Rosenvilde J; Daugaard G; Medici CR; Jørgensen NR; Bandak M
Acta Oncol; 2023 Jul; 62(7):689-695. PubMed ID: 37151105
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Serum Insulin-like Factor 3 Quantification by LC-MS/MS as a Biomarker of Leydig Cell Function.
Albrethsen J; Johannsen TH; Jørgensen N; Frederiksen H; Sennels HP; Jørgensen HL; Fahrenkrug J; Petersen JH; Linneberg A; Nordkap L; Bang AK; Andersson AM; Juul A
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32211773
[TBL] [Abstract][Full Text] [Related]
8. Quantification of the Leydig cell compartment in testicular biopsies and association with biochemical Leydig cell dysfunction in testicular cancer survivors.
Tarsitano MG; Bandak M; Jørgensen N; Skakkebaek NE; Juul A; Lenzi A; Daugaard G; Rajpert-De Meyts E
Andrology; 2018 Sep; 6(5):748-755. PubMed ID: 29981219
[TBL] [Abstract][Full Text] [Related]
9. Effects of acute hCG stimulation on serum INSL3 and 25-OH vitamin D in Klinefelter syndrome.
Santi D; Ivell R; Anand-Ivell R; De Toni L; Fanelli F; Mezzullo M; Pelusi C; Pagotto U; Belli S; Granata ARM; Roli L; Rochira V; Trenti T; Ferlin A; Simoni M
Andrology; 2020 Nov; 8(6):1720-1727. PubMed ID: 32593193
[TBL] [Abstract][Full Text] [Related]
10. Testicular cancer survivors have shorter anogenital distance that is not increased by 1 year of testosterone replacement therapy.
Priskorn L; Kreiberg M; Bandak M; Lauritsen J; Daugaard G; Petersen JH; Aksglaede L; Juul A; Jørgensen N
Hum Reprod; 2021 Aug; 36(9):2443-2451. PubMed ID: 34223605
[TBL] [Abstract][Full Text] [Related]
11. Human testicular insulin-like factor 3: in relation to development, reproductive hormones and andrological disorders.
Bay K; Andersson AM
Int J Androl; 2011 Apr; 34(2):97-109. PubMed ID: 20550598
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the MA-10 cell line as a model of insl3 regulation and Leydig cell function.
Strong ME; Burd MA; Peterson DG
Anim Reprod Sci; 2019 Sep; 208():106116. PubMed ID: 31405452
[TBL] [Abstract][Full Text] [Related]
13. Semen quality and reproductive hormones before orchiectomy in men with testicular cancer.
Petersen PM; Skakkebaek NE; Vistisen K; Rørth M; Giwercman A
J Clin Oncol; 1999 Mar; 17(3):941-7. PubMed ID: 10071288
[TBL] [Abstract][Full Text] [Related]
14. Comparison of testosterone and insulin-like peptide 3 secretions in response to human chorionic gonadotropin in cultured interstitial cells from scrotal and retained testes in dogs.
Pathirana IN; Ashida Y; Kawate N; Tanaka K; Tsuji M; Takahashi M; Hatoya S; Inaba T; Tamada H
Anim Reprod Sci; 2011 Mar; 124(1-2):138-44. PubMed ID: 21377298
[TBL] [Abstract][Full Text] [Related]
15. Serum Insulin-like Factor 3, Testosterone, and LH in Experimental and Therapeutic Testicular Suppression.
Albrethsen J; Østergren PB; Norup PB; Sønksen J; Fode M; Kistorp C; Nordsborg NB; Solheim SA; Mørkeberg J; Main KM; Juul A
J Clin Endocrinol Metab; 2023 Oct; 108(11):2834-2839. PubMed ID: 37235781
[TBL] [Abstract][Full Text] [Related]
16. Anti-Müllerian hormone, testosterone, and insulin-like peptide 3 as biomarkers of Sertoli and Leydig cell function during deslorelin-induced testicular downregulation in the dog.
Balogh O; Somoskői B; Kollár E; Kowalewski MP; Gram A; Reichler IM; Klein R; Kawate N; Mester L; Walter B; Müller L
Theriogenology; 2021 Nov; 175():100-110. PubMed ID: 34534687
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center study of 281 patients.
Trabado S; Maione L; Bry-Gauillard H; Affres H; Salenave S; Sarfati J; Bouvattier C; Delemer B; Chanson P; Le Bouc Y; Brailly-Tabard S; Young J
J Clin Endocrinol Metab; 2014 Feb; 99(2):E268-75. PubMed ID: 24243640
[TBL] [Abstract][Full Text] [Related]
18. Luteinizing hormone regulation by sex steroids in men with germinal and Leydig cell tumours.
Reznik Y; Rieu M; Kuhn JM; Mandard JC; Bottet P; Lemonnier D; Bekka S; Mahoudeau J
Clin Endocrinol (Oxf); 1993 May; 38(5):487-93. PubMed ID: 8392454
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like peptide 3 stimulates testosterone secretion in mouse Leydig cells via cAMP pathway.
Pathirana IN; Kawate N; Büllesbach EE; Takahashi M; Hatoya S; Inaba T; Tamada H
Regul Pept; 2012 Oct; 178(1-3):102-6. PubMed ID: 22800961
[TBL] [Abstract][Full Text] [Related]
20. Serum insulin-like factor 3 is highly correlated with intratesticular testosterone in normal men with acute, experimental gonadotropin deficiency stimulated with low-dose human chorionic gonadotropin: a randomized, controlled trial.
Roth MY; Lin K; Bay K; Amory JK; Anawalt BD; Matsumoto AM; Marck BT; Bremner WJ; Page ST
Fertil Steril; 2013 Jan; 99(1):132-139. PubMed ID: 23040523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
